Amgen partners with Biocartis on diagnostic tests for cancer drug
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →SerImmune gets $8 million in financing from Illumina Ventures
Santa Barbara immunotherapy and diagnostic company SerImmune received $8 million in financing from San Francisco-based Illumina Ventures to expand its immune mapping platform and database. Illumina invests primarily in early-stage companies researching genomics, life science and health care. A subsidiary of pharmaceutical giant Merck also participated in the financing round, alongside other undisclosed investors. Mapping Read More →
Read More →Cynvenio inks deal with Milenia Labs to distribute blood test
Westlake Village cancer treatment company Cynvenio Biosystems announced an exclusive agreement with diagnostic test company Milenia Labs to distribute a blood test for breast cancer at its 12 diagnostic centers in Mexico. Financial details of the deal were not disclosed. The test provides real-time information about cancer cell activity for patients who have completed treatment Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
